Efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors for Chinese patients with squamous cell carcinoma of lung harboring EGFR mutation

OBJECTIVE: Epidermal growth factor receptor (EGFR) mutation mostly occurred in lung adenocarcinoma, rarely in squamous cell carcinoma (SQCC). EGFR mutation rate in SQCC varied in previous reports, and the efficacy of EGFR tyrosine kinase inhibitors (TKIs) in SQCC harboring EGFR mutation has not yet...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Fang, Wenfeng, Zhang, Jianwei, Liang, Wenhua, Huang, Yan, Yan, Yue, Wu, Xuan, Hu, Zhihuang, Ma, Yuxiang, Zhao, Hongyun, Zhao, Yuanyuan, Yang, Yunpeng, Xue, Cong, Zhang, Jing, Zhang, Li
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Pioneer Bioscience Publishing Company 2013
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3815724/
https://ncbi.nlm.nih.gov/pubmed/24255770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2013.09.15
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia